Multiple sources of contamination in samples from patients reported to have XMRV infection

Mary F Kearney1, Jonathan Spindler, Ann Wiegand

  • 1HIV Drug Resistance Program, National Cancer Institute, Frederick, Maryland, United States of America. kearneym@mail.nih.gov

Plos One
|February 25, 2012
PubMed